NOT-NS-23-112: Notice of Availability of Frequently Asked Questions (FAQs) for PAR-23-289: Diagnostic Centers of Excellence for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)

Notice of Availability of Frequently Asked Questions (FAQs) for PAR-23-289: Diagnostic Centers of Excellence for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)

Notice Number:

NOT-NS-23-112

Key Dates

Release Date:

October 16, 2023

Related Announcements

August 31, 2023 - Diagnostic Centers of Excellence for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed). See Announcement PAR-23-289
July 17, 2023 - Notice of Intent to Publish a Funding Opportunity Announcement for Diagnostic Centers of Excellence (U01 - Clinical Trial Not Allowed). See Notice NOT-NS-23-096
June 6, 2022 - Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed). See Announcement RFA-NS-22-051,

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this Notice is to announce the posting of the Frequently Asked Questions (FAQs) regarding the Notice of Funding Opportunity Announcement PAR-23-289 for Diagnostic Centers of Excellence for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed). They are available for viewing on the NINDS UDN webpage.

Inquiries

Please direct all inquiries to:

Argenia Doss
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-827-6369
Email: argenia.doss@nih.gov

Laura Mamounas
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5745
Email: mamounal@ninds.nih.gov

Adam L. Hartman
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9135
E-mail: adam.hartman@nih.gov